Cargando…
Domiciliary high-flow treatment in patients with COPD and chronic hypoxic failure: In whom can we reduce exacerbations and hospitalizations?
INTRODUCTION: Domiciliary High-flow, humidified, nasal cannula (HFNC) is a possible add-on in patients with chronic respiratory diseases. This post-hoc study investigates benefit of HFNC in subgroups of advanced COPD patients with chronic hypoxic failure on reduction of exacerbations and hospitaliza...
Autor principal: | Weinreich, Ulla Møller |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937157/ https://www.ncbi.nlm.nih.gov/pubmed/31887206 http://dx.doi.org/10.1371/journal.pone.0227221 |
Ejemplares similares
-
Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure
por: Sørensen, Sabrina Storgaard, et al.
Publicado: (2021) -
Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations
por: Crooks, Michael G., et al.
Publicado: (2021) -
The effect of domiciliary high flow nasal cannula treatment on dyspnea and walking distance in patients with interstitial lung disease – A pilot study
por: Weinreich, Ulla Møller, et al.
Publicado: (2022) -
Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure
por: Storgaard, Line Hust, et al.
Publicado: (2018) -
Employment Status, Readmission and Mortality After Acute Exacerbation of COPD
por: Jacobsen, Peter Ascanius, et al.
Publicado: (2021)